Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma - Contacts and Locations

Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma

This study is currently recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00670358

Locations


United States, Arizona
	Mayo Clinic Scottsdale	Recruiting
	Scottsdale, Arizona, United States, 85259-5499
	Contact: Clinical Trials Office - All Mayo Clinic Locations 507-538-7623

United States, Minnesota
	Mayo Clinic Cancer Center	Recruiting
	Rochester, Minnesota, United States, 55905
	Contact: Clinical Trials Office - All Mayo Clinic Locations 507-538-7623

Sponsors and Collaborators

Mayo Clinic

National Cancer Institute (NCI)

Investigators


Principal Investigator:	Thomas E. Witzig, MD	Mayo Clinic

Investigator:	Craig B. Reeder, MD	Mayo Clinic Scottsdale